Further support for our results comes from the finding that an activating mutation in Flt3 leads to the development of a myeloproliferative disorder 73 that is characterized by increased numbers of GMPs and an accumulation of mature myeloid cells 74–76. Here, FLT3 is linked to myeloproliferative disorder.